Product News – Spring Edition Product News – Spring Edition
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing

UCB have announced a new biologics facility in Gwinnett County, GA, US. As innovative medicines reach more patients, the path forward includes expanded manufacturing capacity in the US, with the new biologics facility designed to meet increasing demand and ensure patients receive reliable, timely access to vital treatments. The Georgia facility will complement its global network and strengthen partnerships, including its US-based contract manufacturing organisation (CMO) network. This approach boosts its ability to deliver at scale without compromising on quality.

Spanning 460,000 square feet on 79 acres, the site will serve as a cornerstone of its biologics network, with robust infrastructure and an expert team. By weaving in artificial intelligence, robotics and smart resource management, its digital-first approach not only strengthens efficiency and sustainability, but also reflects its shared pride in building a truly resilient supply chain. By opening this new campus, it will create around 330 permanent, skilled jobs in biologics manufacturing and more than 1,000 construction jobs. Together, the company is supporting a growing workforce and generating an estimated $5bn in economic impact for the area.